These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15197782)

  • 1. Differential expression of 9-O-acetylated sialoglycoconjugates on leukemic blasts: a potential tool for long-term monitoring of children with acute lymphoblastic leukemia.
    Pal S; Ghosh S; Bandyopadhyay S; Mandal C; Bandhyopadhyay S; Kumar Bhattacharya D; Mandal C
    Int J Cancer; 2004 Aug; 111(2):270-7. PubMed ID: 15197782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased interferon gamma production by peripheral blood mononuclear cells in response to stimulation of overexpressed disease-specific 9-O-acetylated sialoglycoconjugates in children suffering from acute lymphoblastic leukaemia.
    Ghosh S; Bandyopadhyay S; Pal S; Das B; Bhattacharya DK; Mandal C
    Br J Haematol; 2005 Jan; 128(1):35-41. PubMed ID: 15606547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of immune-complexed 9-O-acetylated sialoglycoconjugates in the sera of patients with pediatric acute lymphoblastic leukemia.
    Bandyopadhyay S; Mukherjee K; Chatterjee M; Bhattacharya DK; Mandal C
    J Immunol Methods; 2005 Feb; 297(1-2):13-26. PubMed ID: 15777927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against 9-O-acetylated sialic acids in childhood acute lymphoblastic leukemia: a two-year study with 186 samples following protocol MCP 943.
    Bandyopadhyay S; Chatterjee M; Banavali SD; Pal S; Nair CN; Advani SH; Mandal C
    Indian J Biochem Biophys; 2006 Feb; 43(1):7-14. PubMed ID: 16955745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon gamma promotes survival of lymphoblasts overexpressing 9-O-acetylated sialoglycoconjugates in childhood acute lymphoblastic leukaemia (ALL).
    Ghosh S; Bandyopadhyay S; Mallick A; Pal S; Vlasak R; Bhattacharya DK; Mandal C
    J Cell Biochem; 2005 May; 95(1):206-16. PubMed ID: 15770663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-acetyl sialic acid specific IgM in childhood acute lymphoblastic leukaemia.
    Pal S; Chatterjee M; Bhattacharya DK; Bandhyopadhyay S; Mandal C; Mandal C
    Glycoconj J; 2001 Jul; 18(7):529-37. PubMed ID: 12151714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of 9-O-acetylated sialoglycoproteins from leukemic cells and their potential as immunological tool for monitoring childhood acute lymphoblastic leukemia.
    Pal S; Ghosh S; Mandal C; Kohla G; Brossmer R; Isecke R; Merling A; Schauer R; Schwartz-Albiez R; Bhattacharya DK; Mandal C
    Glycobiology; 2004 Oct; 14(10):859-70. PubMed ID: 15190007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against 9-O-acetylated sialoglycans: a potent marker to monitor clinical status in childhood acute lymphoblastic leukemia.
    Pal S; Bandyopadhyay S; Chatterjee M; Bhattacharya DK; Minto L; Hall AG; Mandal C
    Clin Biochem; 2004 May; 37(5):395-403. PubMed ID: 15087256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-expressed IgG2 antibodies against O-acetylated sialoglycoconjugates incapable of proper effector functioning in childhood acute lymphoblastic leukemia.
    Bandyopadhyay S; Bhattacharyya A; Mallick A; Sen AK; Tripathi G; Das T; Sa G; Bhattacharya DK; Mandal C
    Int Immunol; 2005 Feb; 17(2):177-91. PubMed ID: 15629900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow-cytometric monitoring of disease-associated expression of 9-O-acetylated sialoglycoproteins in combination with known CD antigens, as an index for MRD in children with acute lymphoblastic leukaemia: a two-year longitudinal follow-up study.
    Chowdhury S; Bandyopadhyay S; Mandal C; Chandra S; Mandal C
    BMC Cancer; 2008 Feb; 8():40. PubMed ID: 18241334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable degree of alternative complement pathway-mediated hemolysis in Indian visceral leishmaniasis induced by differential expression of 9-O-acetylated sialoglycans.
    Chava AK; Chatterjee M; Sharma V; Sundar S; Mandal C
    J Infect Dis; 2004 Apr; 189(7):1257-64. PubMed ID: 15031795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.
    Eckert C; von Stackelberg A; Seeger K; Groeneveld TW; Peters C; Klingebiel T; Borkhardt A; Schrappe M; Escherich G; Henze G
    Eur J Cancer; 2013 Apr; 49(6):1346-55. PubMed ID: 23265714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-acetyl sialic acid binding lectin as a probe for detection of subtle change on cell surface induced during acute lymphoblastic leukemia (ALL) and its clinical application.
    Mandal C; Sinha D; Sharma V; Bhattacharya DK
    Indian J Biochem Biophys; 1997; 34(1-2):82-6. PubMed ID: 9343933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered erythrocyte membrane characteristics during anemia in childhood acute lymphoblastic leukemia.
    Ghosh S; Bandyopadhyay S; Bhattacharya DK; Mandal C
    Ann Hematol; 2005 Feb; 84(2):76-84. PubMed ID: 15338196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expressions of ARS2 and CASP8AP2 predict relapse and poor prognosis in pediatric acute lymphoblastic leukemia patients treated on China CCLG-ALL 2008 protocol.
    Cui L; Gao C; Zhang RD; Jiao Y; Li WJ; Zhao XX; Liu SG; Yue ZX; Zheng HY; Deng GR; Wu MY; Li ZG; Jia HT
    Leuk Res; 2015 Feb; 39(2):115-23. PubMed ID: 25530566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia.
    Pal S; Chatterjee M; Bhattacharya DK; Bandhyopadhyay S; Mandal C
    Glycobiology; 2000 Jun; 10(6):539-49. PubMed ID: 10814695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
    zur Stadt U; Harms DO; Schlüter S; Jorch N; Spaar HJ; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H
    Klin Padiatr; 2000; 212(4):169-73. PubMed ID: 10994545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemia.
    Laughton SJ; Ashton LJ; Kwan E; Norris MD; Haber M; Marshall GM
    J Clin Oncol; 2005 Apr; 23(10):2264-71. PubMed ID: 15800317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse of acute lymphoblastic leukemia in children in the context of microarray analyses.
    Szczepanek J; Styczyński J; Haus O; Tretyn A; Wysocki M
    Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):61-8. PubMed ID: 21246408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.